Metraipolis › archive › dc_ce79f2f92031
The radioenhancer NBTXR3: bridging physics and biology to improve radiotherapy outcomes and prime anti-tumor immunity — Europe PMC PMID:41408568
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41408568
- DOI
- 10.1186/s13046-[numero omesso]-1
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T14:17:32.949Z
- SHA-256 of the archived text
132e641697f87e274b9630ae06e5738c0f74086091428ac26f84d01155c03795- Stable URL of this page
https://metraipolis.com/documento/dc_ce79f2f92031
How to cite
The radioenhancer NBTXR3: bridging physics and biology to improve radiotherapy outcomes and prime anti-tumor immunity — Europe PMC PMID:41408568 — Europe PMC (en), https://europepmc.org/article/MED/41408568 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce79f2f92031 (Metraipolis archive dc_ce79f2f92031, sha256 132e641697f87e274b9630ae06e5738c0f74086091428ac26f84d01155c03795)
BibTeX
@misc{dcce79f2f92031,
title = {The radioenhancer NBTXR3: bridging physics and biology to improve radiotherapy outcomes and prime anti-tumor immunity — Europe PMC PMID:41408568},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41408568},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce79f2f92031; sha256 132e641697f87e274b9630ae06e5738c0f74086091428ac26f84d01155c03795},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41408568. Agents can read the archived copy with the MCP tool read_document.